⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10373598 | 0.81 | — | — | |
| SCHEMBL17200005 | 0.75 | EPHX2 (0.36) | — | |
| SCHEMBL20376102 | 0.74 | CHRNB2 (0.38) | — | |
| SCHEMBL9525312 | 0.74 | EPHX2 (0.38) | — | |
| SCHEMBL20201749 | 0.74 | CHRNB2 (0.48) | — | |
| SCHEMBL25795055 | 0.71 | CHRNA1 (0.34) | — | |
| SCHEMBL14069079 | 0.71 | RAB9A (0.40) | — | |
| SCHEMBL3303061 | 0.70 | — | — | |
| SCHEMBL171777 | 0.70 | — | — | |
| SCHEMBL9285410 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10968179-B2 | Charged ion channel blockers and methods for use | Nocion Therapeutics, Inc. (US) | 2021-04-06 | — | — | US | disclosed |
| US-20200290953-A1 | Charged Ion Channel Blockers and Methods for Use | Nocion Therapeutics, Inc. | 2020-09-17 | — | — | US | disclosed |